Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Chewable & Orodispersible Aids
Taste Masking
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Diclazuril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclazuril manufacturer or Diclazuril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclazuril manufacturer or Diclazuril supplier.
PharmaCompass also assists you with knowing the Diclazuril API Price utilized in the formulation of products. Diclazuril API Price is not always fixed or binding as the Diclazuril Price is obtained through a variety of data sources. The Diclazuril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diclazuril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diclazuril, including repackagers and relabelers. The FDA regulates Diclazuril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diclazuril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diclazuril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diclazuril supplier is an individual or a company that provides Diclazuril active pharmaceutical ingredient (API) or Diclazuril finished formulations upon request. The Diclazuril suppliers may include Diclazuril API manufacturers, exporters, distributors and traders.
click here to find a list of Diclazuril suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Diclazuril DMF (Drug Master File) is a document detailing the whole manufacturing process of Diclazuril active pharmaceutical ingredient (API) in detail. Different forms of Diclazuril DMFs exist exist since differing nations have different regulations, such as Diclazuril USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diclazuril DMF submitted to regulatory agencies in the US is known as a USDMF. Diclazuril USDMF includes data on Diclazuril's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diclazuril USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diclazuril suppliers with USDMF on PharmaCompass.
A Diclazuril CEP of the European Pharmacopoeia monograph is often referred to as a Diclazuril Certificate of Suitability (COS). The purpose of a Diclazuril CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diclazuril EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diclazuril to their clients by showing that a Diclazuril CEP has been issued for it. The manufacturer submits a Diclazuril CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diclazuril CEP holder for the record. Additionally, the data presented in the Diclazuril CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diclazuril DMF.
A Diclazuril CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diclazuril CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diclazuril suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diclazuril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diclazuril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diclazuril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diclazuril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diclazuril NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diclazuril suppliers with NDC on PharmaCompass.
Diclazuril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diclazuril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diclazuril GMP manufacturer or Diclazuril GMP API supplier for your needs.
A Diclazuril CoA (Certificate of Analysis) is a formal document that attests to Diclazuril's compliance with Diclazuril specifications and serves as a tool for batch-level quality control.
Diclazuril CoA mostly includes findings from lab analyses of a specific batch. For each Diclazuril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diclazuril may be tested according to a variety of international standards, such as European Pharmacopoeia (Diclazuril EP), Diclazuril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diclazuril USP).
